In particular, leukemic blasts from patients aged less than 65 years may express high levels of CD112 and CD155 in order to decrease DNAM-1 expression on NK cells [61], an event which leads to an altered degranulation of NK cells causing impaired killing of blasts in AML and MDS [62,63]. This evidence concerns the gene NECTIN2 and acute myeloid leukemia.